Effect of inulin-type fructans on appetite in patients with type 2 diabetes: a randomised controlled crossover trial

J Nutr Sci. 2021 Sep 10:10:e72. doi: 10.1017/jns.2021.70. eCollection 2021.

Abstract

The aim of the study was to investigate the effect of prebiotic fibres on appetite-regulating hormones, subjective feeling of appetite and energy intake in subjects with type 2 diabetes. Data presented are secondary outcomes of a study investigating the effect of prebiotics on glucagon-like peptide-1 and glycaemic regulation. We conducted a randomised and placebo-controlled crossover trial to evaluate the effects of 16 g/d of inulin-type fructans or a control supplement (maltodextrin) for 6 weeks in randomised order, with a 4-week washout period in-between, on appetite in thirty-five men and women with type 2 diabetes. Data were collected at visits before and after each treatment: plasma concentration of the satiety-related peptides ghrelin and peptide YY (PYY) were assessed during a standardised mixed meal. The subjective sensation of appetite was evaluated in response to an ad libitum lunch by rating the visual analogue scale. Twenty-nine individuals (twelve women) were included in the analyses. Compared to control treatment, the prebiotics did not affect ghrelin (P =0⋅71) or the ratings of hunger (P = 0⋅62), satiety (P = 0⋅56), fullness (P = 0⋅73) or prospective food consumption (P = 0⋅98). Energy intake also did not differ between the treatments. However, the response of PYY increased significantly after the control treatment with mean (sem) 11⋅1 (4⋅3) pg/ml when compared to the prebiotics -0⋅3 (4⋅3) pg/ml (P = 0⋅013). We observed no effect of inulin-type fructans on appetite hormones, subjective feeling of appetite or energy intake in patients with type 2 diabetes.

Keywords: Diabetes type 2; GLP-1, glucagon-like peptide-1; Ghrelin; ITF, inulin-type fructans; PYY; PYY, peptide YY; Prebiotics; Standardised mixed meal; VAS, visual analogue scale.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Appetite*
  • Cross-Over Studies
  • Diabetes Mellitus, Type 2* / drug therapy
  • Female
  • Ghrelin / blood
  • Humans
  • Inulin / administration & dosage*
  • Male
  • Peptide YY / blood
  • Prebiotics*
  • Prospective Studies
  • Satiation

Substances

  • Ghrelin
  • Prebiotics
  • Peptide YY
  • Inulin